Jordi Mata-Fink
Chief Executive Officer at Gate Bioscience, Inc.
Profile
Jordi Mata-Fink is the founder of Cygnal Therapeutics, Inc. (founded in 2017), Rubius Therapeutics, Inc. (founded in 2014), and Gate Bioscience, Inc. (founded in 2021).
He held the title of Director of Research at Rubius Therapeutics, Inc. Dr. Mata-Fink's current job is at Flagship Pioneering, where he has been a Principal since 2013.
In terms of education, Dr. Mata-Fink attended Stanford University for undergraduate and graduate studies and obtained a doctorate degree from the Massachusetts Institute of Technology.
Jordi Mata-Fink active positions
| Companies | Position | Start |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Analyst | 2012-12-31 |
Gate Bioscience, Inc.
 Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Chief Executive Officer | 2020-12-31 |
Former positions of Jordi Mata-Fink
| Companies | Position | End |
|---|---|---|
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Founder | - |
| RUBIUS THERAPEUTICS | Founder | - |
Training of Jordi Mata-Fink
| Stanford University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Gate Bioscience, Inc.
Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Health Technology |
- Stock Market
- Insiders
- Jordi Mata-Fink
